Clinical Trial Update: A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating etrasimod in moderately to severely active ulcerative colitis is underway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Everstar Therapeutics Limited | Conditions: Moderately to Severely Active Ulcerative Colitis | Phase 3 | Status: UNKNOWN